Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: Presence in human plasma

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2281-2289

  Söderberg, Anita ^a   Sahaf, Bita ^a   Rosén, Anders ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ARTICLE; CANCER GROWTH; HUMAN; HUMAN CELL; LEUKEMIA; MELANOMA; MONOCYTE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN SECRETION;

AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOLGI APPARATUS; HUMANS; INSULIN; INTERFERON TYPE II; INTERLEUKIN-1; LEUKEMIA; LIPOPOLYSACCHARIDES; MELANOMA; MICE; MONOCYTES; OXIDATION-REDUCTION; PROTEINS; REACTIVE OXYGEN SPECIES; SELENOPROTEINS; SODIUM SELENITE; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TUMOR CELLS, CULTURED;

EID: 0242501629     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Holmgren, A., and Björnstedt, M. Thioredoxin and thioredoxin reductase. Methods Enzymol., 52: 199-208, 1995.
2. Nakamura, H., Nakamura, K., and Yodoi, J. Redox regulation of cellular activation. Annu. Rev. Immunol., 15, 351-369, 1997.
3. Luthman, M., and Holmgren, A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry, 21: 6628-6633, 1982.
4. Gasdaska, P. Y., Gasdaska, J. R., Cochran, S., and Powis, G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett., 373: 5-9, 1995.
5. Gladyshev, V. N., Jeang, K. T., and Stadtman, T. C. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA, 93: 6146-6151, 1996.
6. Zhong, L., Arnér, E. S. J., Ljung, J., Åslund, F., and Holmgren, A. Rat and calf thioredoxin reductase are homologous to glutathione reduclase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate seleno-cysteine residue. J. Biol. Chem., 270: 11761-11764, 1998.
7. Sun, Q-A., Wu, Y., Zappacosta, F., Jeang, K-T., Lee, B. J., Hatfield, D. L., and Gladyshev, V. N. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J. Biol. Chem., 274: 24522-24530, 1999.
8. Gasdaska, P. Y., Berggren, M. M., Berry, M. J., and Powis, G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett., 442: 105-111, 1999.
9. Miranda-Vizuete, A, Damdimopoulos, A. E., Pedrajas, J. R., Gustavsson, J-Å., and Spyrou, G. Human mitochondrial thioredoxin reductase: cDNA cloning, expression and genomic organization. Eur. J. Biochem., 261: 405-412, 1999.
10. Lee, S-R., Kim, J-R., Kwon, K-S., Yoon, H. W., Levine, R. L., Ginsburg, A., and Ree, S. G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem., 274: 4722-4734, 1999.
11. Andersson, M., Holmgren, A., and Spyrou, G. NK-lysin, a disulfide containing effector peptide of T-lymphocytes is reduced and inactivated by human thioredoxin reductase. J. Biol. Chem., 271: 10116-10120, 1996.
12. Rozell, B., Hansson, H. A., Luthman, M., and Holmgren, A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur. J. Cell Biol., 38: 79-86, 1985.
13. Schallreuter, K. U., Pittelkow, M. R., and Wood, J. M. Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous keratinocytes. J. Invest. Dermatol., 87: 728-732, 1986.
14. Bertini, R., Howard, O. M. Z., Dong, H-F., Oppenheim, J. J., Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B., Wilshire, J. A., Mengozzi, M., Nakamura, H., Yodoi, J., Pekkari, K., Guranath, R., Holmgren, A., Herzenberg, L. A., Herzenberg, L. A., and Ghezzi, P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med., 189: 1-8, 1999.
15. Powis, G., Briehl, M., and Oblong, J. Redox signaling and the control of cell growth and death. Pharmacol. Ther., 68: 149-173, 1995.
16. Koishi, R., Kawashima, I., Yoshimura, C., Sugawara, M., and Serizawa, N. Cloning and characterization of a novel oxidoreductase KDRF from a human bone marrow-derived stromal cell line KM-102. J. Biol. Chem., 272, 2570-2577, 1997.
17. Miranda-Vizuete, A., and Spyrou, G. The novel oxidoreductase KDRF is identical to human thioredoxin reductase. Biochem. J., 325: 287-288, 1997.
18. Tamura, T., and Stadtman, T. C. A new selenoprotein from human lung adenocarcinoma cells purification, properties and thioredoxin activity. Proc. Natl. Acad. Sci. USA, 93: 1006-1011, 1996.
19. Söderberg, A., Sahaf, B., Holmgren, A., and Rosén, A. Monoclonal antibodies to human thioredoxin reductase. Biochem. Biophys. Res. Commun., 249: 86-89, 1998.
20. Sahaf, B., Söderberg, A., Spyrou, G., Barral, A. M., Pekkari, K., Holmgren, A., and Rosén, A. Thioredoxin expression and localization in human cell lines: Detection of full-length and truncated species. Exp. Cell Res., 236: 181-192, 1997.
21. Kintner, C., and Sugden, B. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature (Lond.), 294: 458-460, 1981.
22. Sundström, C., and Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer, 17: 565-577, 1976.
23. Kirkin, A., Petersen, T., and Olsen, A. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother., 41: 71-81, 1995.
24. Tsuchida, S., Yambe, M., Yamaguchi, Y., Kobayashi, Y., Kanno, T., and Tada, K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer, 26: 171-176, 1980.
25. Katamine, S., Otsu, M., Tsuchiya, S., Sato, T., Ishida, N., Honjo, T., and Ono, Y. Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements. Nature (Lond.), 309: 369-371, 1984.
26. Lirvall, M., Ljungqvist-Höddelius, P., Wasteson, Å., and Magnusson, K-E. UVB radiation affects the mobility of epidermal growth factor receptors in human keratinocytes and fibroblasts. Biosci. Rep., 16: 227-238, 1996.
27. Rheinwald, J. C., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6: 331-344, 1975.
28. Freundlich, B., and Avdalovic, N. Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J. Immunol. Methods, 62: 31-37, 1983.
29. Czerkinsky, C. C., Tarkowski, A., Nilsson, L. A., Ouchterlony, O., Nygren, H., and Gretzer, C. Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J. Immunol. Methods. 72: 489-496, 1984.
30. Johansson, A., and Dahlgren, C. Characterization of the luminol-amplified light-generating reaction induced in human monocytes. J. Leukoc. Biol., 45: 444-451, 1989.
31. Sander, B., Hoiden, B., Andersson, U., Möller, E., and Abrams, J. S. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J. Immunol. Methods, 166: 201-214, 1993.
32. Ericson, M., Hörling, J., Wendel-Hansen, V., Holmgren, A., and Rosén, A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res., 11: 201-207, 1992.
33. Rosén, A., Lundman, P., Carlsson, M., Bhavani, K., Srinivasa, B. R., Kjellström, G., Nilsson, K., and Holmgren, A. A CD4+ T-cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int Immunol., 7: 625-633, 1995.
34. Rubartelli, A., Bajetto, A., Allavena, G., and Sitia, R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem., 267: 24161-24164, 1992.
35. Schallreuter, K. U., and Wood, J. M. New aspects in the pathophysiology of cutaneous melanoma: a review of the role of thioproteins and the effect of nitrosourea. Melanoma Res., 1: 159-167, 1991.
36. Berggren, M., Gallegos, A., Gasdaska, J. R., Gasdaska, P. Y., Warneke, J., and Powis, G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res., 16: 3459-3466, 1996.
37. Nakamura, H., De Rosa, S., Roederer, M., Anderson, M. T., Gregson Dubs, J., Yodoi, J., Holmgren, A., Herzenberg, L., and Herzenberg, L. Elevation of plasma thioredoxin in HIV-infected individuals. Int. Immunol., 8: 603-611, 1996.
38. Cha, M. K., and Kim, I. H. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochem. Biophys. Res. Commun., 217: 900-907, 1995.
39. Apffel, C. A., and Walker, J. E. Tumor growth and disulfide reduction: Possible dependence on protein-disulfide reductase. J. Natl. Cancer Inst., 51: 575-583, 1973.
40. Holmgren, A. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J. Biol. Chem., 252: 4600-4606, 1977.
41. Björnstedt, M., Xue, J., Huang, W., Åkesson, B., and Holmgren, A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J. Biol. Chem., 269: 29382-29384, 1994.
42. Andersson, M., Gunne, H., Agerberth, B., Boman, A., Bergman, T., Sillard, R., Jörnvall, H., Mutt, V., Olsson, B., Wigzell, H., Dagerlind, Å, Boman, G. H., and Gudmundsson, H. NK-lysin, a novel effector peptide of cytotoxic T and NK cells Structure and cDNA cloning of the porcine form, induction by interleukin 2, anti-bacterial and antitumour activity. EMBO J., 14: 1615-1625, 1995.
43. Gozin, A., Franzini, E., Andrieu, V., Da Costa, L., Rollet-Labelle, E., and Pasquier, C. Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic. Biol. Med., 25: 1021-1032, 1998.
44. Gallegos, A., Gasdaska, J. R., Taylor, C. W., Paine-Murietta, G. D., Goodman, D., Gasdaska, P. Y., Berggren, M., Briehl, M. M., and Powis, G. Transfection with human thioredoxin increased cell proliferation and dominant negative mutant thioredoxin reversed the transformed phenotype of breast cancer cells. Cancer Res., 56: 5765-5770, 1996.
45. Thelander, L. Thioredoxin reductase. Characterization of a homogenous preparation from Escherichia coli B. J. Biol. Chem., 242: 852-859, 1967.
46. Zhang, P., Liu, P., Kang, S. W., Seo, M. S., Rhee, S. G., and Obeid, L. M. Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of bcl-2. J. Biol. Chem., 272, 30615-30618, 1997.
47. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazano, K., and Ichijo, H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J, 17: 2596-2606, 1998.
48. Schenk, H., Vogt, M., Dröge, W., and Schulze-Osthoff, K. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol., 156: 765-771, 1996.
49. Nilsson, J., Söderberg, O., Nilsson, K., and Rosén, A. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood, 95: 1420-1426, 2000.
50. Furuke, K., Sasada, T., Ueda-Taniguhi, Y., Yamauchi, A., Inamoto, T., Yamaoka, Y., Masutani, Y., and Yodoi, J. Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type 1-infected lymphocytes by 13-cis-retinoic acid. Cancer Res., 57: 4916-4923, 1997.
51. Taniguchi, Y. U., Furuke, K., Masutani, H., Nakamura, H., and Yodoi, J. Cell cycle inhibition of HTLV-1 transformed T cell lines by retinoic acid: The possible therapeutic use of thioredoxin reductase inhibitors. Oncology Res., 7: 183-189, 1995.
52. Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., and Yodoi, J. Redox regulation of caspase-3 (-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J. Immunol., 161: 6689-6695, 1998.
53. Spyrou, G., Björnstedt, M. Skog, S., and Holmgren, A. Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res., 19: 4407-4412, 1996.
54. Gladyshev, V. N., Stadtman, T. C., Hatfield, D. L., and Jeang, K. T. Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc. Natl. Acad. Sci. USA, 3: 835-839, 1999.
55. Clark, L. C., Jr., Combs, J. J., Turnball, B. W., Slate, E., Chalker, D. K., Chow, J., Davis, L., Glover, R. A., Graham, G. F., and Gross, E. G. Effects of supplementation for cancer prevention in patients with carcinoma of the skin: a randomized clinical trial. J. Am. Med. Assoc., 276: 1957-1963, 1996.
56. Matsuda, M., Masutani, H., Nakamura, H., Miyajima, S., Yamauchi, A., Yonehara, S., Uchida, A., Irimajiri, K., Horiuchi, A., and Yodoi. J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol., 11: 3837-3841, 1991.